New anticoagulants: anti IIa vs anti Xa--is one better? (Q33370261)

26 July 2017

1 reference

title

New anticoagulants: anti IIa vs anti Xa--is one better? (English)

1 reference

26 July 2017

1 reference

1 reference

Kenneth A Bauer

1

1 reference

26 July 2017

publication date

1 February 2006

1 reference

Journal of Thrombosis and Thrombolysis

26 July 2017

published in

1 reference

26 July 2017

volume

21

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

67-72

1 reference

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-006-5579-4

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

21 January 2018

1 reference

12 December 2020

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

1 reference

12 December 2020

New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

1 reference

12 December 2020

Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.

1 reference

12 December 2020

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

12 December 2020

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

1 reference

12 December 2020

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

1 reference

12 December 2020

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

1 reference

12 December 2020

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

1 reference

12 December 2020

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

1 reference

12 December 2020

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

1 reference

12 December 2020

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs

1 reference

12 December 2020

10.1007/S11239-006-5579-4

Identifiers

DOI

1 reference

26 July 2017

1 reference